References
- Benvenga S, Campenni A, Ruggeri RM, et al. Hypopituitarism secondary to head trauma. J Clin Endocrinol Metab 2000;85(4): 1353–61
- Summary of the second annual Andropause Consensus Meeting of the Endocrine Society, Beverly Hills, CA, April 28–30, 2000
- Bhasin S, ed. Benefits and risks of treating hypogonadism in the aging male. Endocr Soc Clin Bull Andropause 2002; No. 2
- Yialamas MA, Hayes FJ. Androgens and the aging male. Endocrinol Rounds 2003; 2(1). Available at: http://www.endocrinologyrounds.org. Accessed Aug 5, 2003
- Morley JE, Charlton E, Patrick P, et al. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 2000;49(9): 1239–42
- Perry PJ, Yates WR, Williams RD, et al. Testosterone therapy in late-life major depression in males. J Clin Psychiatry 2002;63(12): 1096–101
- Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 2002;87(2): 589–98
- Singh AB, Hsia S, Alaupovic P, et al. The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men. J Clin Endocrinol Metab 2002;87(1): 136–43
- Hajjar RR, Kaiser FE, Morley JE. Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis. J Clin Endocrinol Metab 1997;82(11): 3793–6
- Viallard JF, Marit G, Mercie P, et al. Polycythaemia as a complication of transdermal testosterone therapy. Br J Haematol 2000;110(1): 237–8
- Dobs AS, Meikle AW, Arver S, et al. Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men. J Clin Endocrinol Metab 1999;84(10): 3469–78
- Gambineri A, Pasquali R. Testosterone therapy in men: clinical and pharmacological perspectives. J Endocrinol Invest 2000;23(3): 196–214
- Zitzmann M, Nieschlag E. Hormone substitution in male hypogonadism. Mol Cell Endocrinol 2000; 161(1–2):73–88
- Novak A, Brod M, Elbers J. Andropause and quality of life: findings from patient focus groups and clinical experts. Maturitas 2002;43(4): 231–7
- Advisory Panel on Testosterone Replacement in Men. Report of National Institute on Aging Advisory Panel on Testosterone Replacement in Men. J Clin Endocrinol Metab 2001;86(10): 4611–7
- Heaton JP. Point: urologists should take an active role in the diagnosis and treatment of hypogonadism in the aging male. Can J Urol 2002;9(6): 1677–80
- Casey RW. Counterpoint: urologists should take an active role in the diagnosis and treatment of hypogonadism in the aging male. Can J Urol 2002;9(6): 1681–3